A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.
Clinical trial NCT05770713 · COMPLETED
Trial details
- NCT number
- NCT05770713
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-12
- Primary completion
- 2023-02-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.